News Conference News SCAI 2023 SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year L.A. McKeown May 31, 2023
News Conference News SCAI 2021 ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later Michael O'Riordan May 06, 2021
News Conference News SCAI 2021 Better Success With Next-Generation Robotic PCI: PRECISION GRX L.A. McKeown April 30, 2021
News Conference News SCAI 2020 Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA Caitlin E. Cox May 20, 2020
News Conference News SCAI 2020 PCI at Ambulatory Surgical Centers: Quality Cannot Suffer, SCAI Says Caitlin E. Cox May 18, 2020
News Conference News SCAI 2020 Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data Caitlin E. Cox May 15, 2020
News Conference News SCAI 2019 FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients Yael L. Maxwell June 04, 2019
News Conference News SCAI 2019 LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER Yael L. Maxwell June 03, 2019
News Conference News SCAI 2019 Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics Yael L. Maxwell May 21, 2019
News Conference News SCAI 2018 PERSPECTIVE: Contemporary Technique and Practice Confer Clinical Success and QoL Benefit for CTO PCI L.A. McKeown April 26, 2018
News Conference News SCAI 2018 Largest CTO PCI Registry to Date Confirms Feasibility, in Expert Hands Yael L. Maxwell April 26, 2018
News Conference News SCAI 2018 ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended L.A. McKeown April 26, 2018
News Conference News SCAI 2017 Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It L.A. McKeown May 19, 2017